Strategies for Extending Metabolomics Studies with Stable Isotope Labelling and Fluxomics
Overview
Affiliations
This is a perspective from the peer session on stable isotope labelling and fluxomics at the Australian & New Zealand Metabolomics Conference (ANZMET) held from 30 March to 1 April 2016 at La Trobe University, Melbourne, Australia. This report summarizes the key points raised in the peer session which focused on the advantages of using stable isotopes in modern metabolomics and the challenges in conducting flux analyses. The session highlighted the utility of stable isotope labelling in generating reference standards for metabolite identification, absolute quantification, and in the measurement of the dynamic activity of metabolic pathways. The advantages and disadvantages of different approaches of fluxomics analyses including flux balance analysis, metabolic flux analysis and kinetic flux profiling were also discussed along with the use of stable isotope labelling in dynamic metabolomics. A number of crucial technical considerations for designing experiments and analyzing data with stable isotope labelling were discussed which included replication, instrumentation, methods of labelling, tracer dilution and data analysis. This report reflects the current viewpoint on the use of stable isotope labelling in metabolomics experiments, identifying it as a great tool with the potential to improve biological interpretation of metabolomics data in a number of ways.
Metabolomic and proteomic applications to exercise biomedicine.
Wilkinson D, Crossland H, Atherton P Transl Exerc Biomed. 2024; 1(1):9-22.
PMID: 38660119 PMC: 11036890. DOI: 10.1515/teb-2024-2006.
Ahmad S, Mohammed M, Mekala L, Anusha R, Sasikala C, Venkata Ramana C World J Microbiol Biotechnol. 2023; 39(4):98.
PMID: 36781830 DOI: 10.1007/s11274-023-03537-z.
Mohd Kamal K, Mahamad Maifiah M, Zhu Y, Abdul Rahim N, Hashim Y, Abdullah Sani M Metabolites. 2022; 12(11).
PMID: 36355168 PMC: 9697766. DOI: 10.3390/metabo12111085.
Recent Trends of Microbiota-Based Microbial Metabolites Metabolism in Liver Disease.
Ganesan R, Jeong J, Kim D, Suk K Front Med (Lausanne). 2022; 9:841281.
PMID: 35615096 PMC: 9125096. DOI: 10.3389/fmed.2022.841281.
Uematsu S, Ohno S, Tanaka K, Hatano A, Kokaji T, Ito Y iScience. 2022; 25(2):103787.
PMID: 35243212 PMC: 8859528. DOI: 10.1016/j.isci.2022.103787.